Advertisement
Advertisement
U.S. markets open in 6 hours 18 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Oxford Nanopore Technologies Limited (ONT.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
289.50+5.00 (+1.76%)
As of 04:35PM BST. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close284.50
Open282.50
Bid306.50 x N/A
Ask302.00 x N/A
Day's Range274.00 - 290.00
52 Week Range239.00 - 736.00
Volume1,691,507
Avg. Volume1,979,669
Market Cap2.382B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-22.90
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est629.63
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ONT.L

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • ACCESSWIRE

      ONT Chosen for Comprehensive Human Genome Program

      Their goal is to gain more scientific insights from the comprehensive genomic dataset and to create a catalogue of structural variation (SV) from a diverse set of individuals. Building on the established 1000 Genomes Project, which produced a broad catalogue of human genomic variation, this project is expected to further our understanding of variation.

    • ACCESSWIRE

      Genomics England Expands Nanopore Use in Cancer

      Genomics England expands use of Oxford Nanopore sequencing in cancerOxford Nanopore technology will be used by Genomics England to investigate and validate at increasing scale the benefits of sequencing for improving patient care and advancing research to develop new treatments. Genomics England's "Long-Read Sequencing Programme" takes advantage of Oxford Nanopore's ability to sequence any-length fragments of DNA, including long and ultra-longOXFORD, UK / ACCESSWIRE / April 4, 2022 / Oxford Nano

    • ACCESSWIRE

      ONT Shows New High-Accuracy, High-Output Chemistry

      Oxford Nanopore technology update: CTO Clive G Brown unveils latest sequencing chemistry with highest performance to date, Short Fragment Mode and latest methylation performance evaluationsClive G Brown, CTO, Oxford Nanopore Technologies, reviews some of the latest technology updates during a webinar today. Highlights include performance and base modification calling improvements, as well as updates on the recently-released Short Fragment Mode (SFM) and a new basecallerOXFORD, UK / ACCESSWIRE /

    Advertisement
    Advertisement